Renalytix Plc ADR (RNLX)

Finanzdaten der Renalytix Plc ADR-Aktie (RNLX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30
Periodenlänge	3 Monate	3 Monate
Revenues	54.47% 0.709	0.459
Cost Of Revenue	4.38% 0.48	0.502
Gross Profit	632.56% 0.229	-0.043
Operating Expenses	0.27% 8.87	8.846
Benefits Costs and Expenses	13.41% 9.19	10.61
Costs And Expenses	13.41% 9.19	10.61
Operating Income/Loss	2.79% -8.641	-8.889
Income/Loss From Equity Method Investments	-	-
Income/Loss From Continuing Operations Before Tax	16.48% -8.481	-10.15
Income Tax Expense/Benefit	0.004	-
Income/Loss From Continuing Operations After Tax	16.44% -8.485	-10.15
Net Income/Loss	16.44% -8.485	-10.15
Preferred Stock Dividends And Other Adjustments	-	-
Attributable To Noncontrolling Interest	-	-
Basic Average Shares	2.64% 97.27	94.77
Diluted Average Shares	2.64% 97.27	94.77
Basic Earnings Per Share	18.18% -0.09	-0.11
Diluted Earnings Per Share	18.18% -0.09	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-